[{"Assets_0_Q3_USD":556953000.0,"CommonStockSharesOutstanding_0_Q3_shares":29654468.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-187902000.0,"NetIncomeLoss_1_Q3_USD":-64454000.0,"NetIncomeLoss_3_Q3_USD":-221237000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":46581000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":124908000.0,"StockholdersEquity_0_Q3_USD":95809000.0,"Ticker":"ICPT","CIK":"1270073","name":"INTERCEPT PHARMACEUTICALS, INC.","OfficialName":"Intercept Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"493490879.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]